IL33 and neoplasm: Instead, confirming previous studies (31, 32), IL-33-deficiency led to a reduction in tumor numbers, and a decrease in tumor mast cells and Tregs, both of which are reported to promote tumorigenesis downstream of IL-33 (fig.